Clinical Trials Browser

Phase NA × Breast Neoplasms × Anthracyclines × Clear all

NCT02521363 2025-08-22

Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer

Phase NA Completed

11 enrolled 7 charts

Breast Neoplasms

NCT04568161 2025-04-03

Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses

Phase NA Completed

Breast Neoplasms, Cardiovascular Diseases, Cardiotoxicity